STAAR Surgical Company (STAA): Price weakness presents buying opportunity - Increased holdings by major investors!

STAAR Surgical Company (STAA) is a leading manufacturer of implantable lenses for eye surgery. The company’s main product is the implantable Collamer lens (ICL), including the groundbreaking EVO ICL technology. These lenses provide an effective, minimally invasive, and reversible alternative to LASIK eye surgery, particularly suited for individuals with severe myopia (-6 diopters and higher), hyperopia, or astigmatism. The goal is to expand the applications of EVO ICL technology to moderate myopia (-3D to -6D) as well as other vision impairments,...